Association of n-6 PUFAs with the risk of diabetic retinopathy in diabetic patients

  title={Association of n-6 PUFAs with the risk of diabetic retinopathy in diabetic patients},
  author={Jushuang Li and Tao Wang and Jingjing Zuo and Cheng-nan Guo and Fang Peng and Shu-zhen Zhao and Hui-hui Li and Xiangqing Hou and Yuan Lan and Yaping Wei and Chao Zheng and Guangyun Mao},
  journal={Endocrine Connections},
  pages={1191 - 1201}
Diabetic retinopathy (DR), the most common microvascular complication of diabetes and leading cause of visual impairment in adults worldwide, is suggested to be linked to abnormal lipid metabolism. The present study aims to comprehensively investigate the relationship between n-6 polyunsaturated fatty acids (PUFAs) and DR. This was a propensity score matching based case–control study, including 69 pairs of DR patients and type 2 diabetic patients without DR with mean age of 56.7 ± 9.2 years… 

Tables from this paper

Serum Untargeted Metabolomics Reveal Potential Biomarkers of Progression of Diabetic Retinopathy in Asians
It is demonstrated that the pathways of arginine biosynthesis metabolism, linoleic acid metabolism, alanine, aspartate, and glutamate metabolism, as well as d-glutamine and d- glutamate metabolism, were dysregulated in DR patients of the Asian population.
Chinmedomics Strategy for Elucidating the Pharmacological Effects and Discovering Bioactive Compounds From Keluoxin Against Diabetic Retinopathy
This study was the first to apply the chinmedomics strategy to discover the effective constituents of KLX in the treatment of DR, which fills the gap of unclear effective constituentsof KLX.
Interpretable machine learning-derived nomogram model for early detection of diabetic retinopathy in type 2 diabetes mellitus: a widely targeted metabolomics study
The developed nomogram model (including diabetes duration, systolic blood pressure and ThTP) shows an excellent quality of classification and has a reasonable degree of calibration, and might be a principal metabolite for DR detection.


The Associations of Dietary Intake of Polyunsaturated Fatty Acids With Diabetic Retinopathy in Well-Controlled Diabetes.
Increasing PUFA intake was associated with a reduced likelihood of the presence and severity of DR in well-controlled diabetes, whereas increasing SFA intakewas associated with an increased likelihood ofThe presence and seriousness of DR.
ω-3 and ω-6 long-chain PUFAs and their enzymatic metabolites in neovascular eye diseases.
Both of the ω-3 and the ψ-6 lipid products of cytochrome P450 oxidase 2C promote neovascularization in both the retina and choroid, which suggests that inhibition of this pathway might be beneficial.
Plasma phospholipid n-3 and n-6 polyunsaturated fatty acids in relation to cardiometabolic markers and gestational diabetes: A longitudinal study within the prospective NICHD Fetal Growth Studies
Null findings on primarily diet-derived n-3 EPA and DHA and n-6 LA do not provide strong evidence to suggest a beneficial role in prevention of GDM, although not excluding the potential benefit of EPA andDHA on glucose–insulin homeostasis given the inverse associations with insulin-resistance markers.
N-3 Polyunsaturated Fatty Acids Prevent Diabetic Retinopathy by Inhibition of Retinal Vascular Damage and Enhanced Endothelial Progenitor Cell Reparative Function
DHA-rich diet fully prevented retinal vascular pathology through inhibition of ASM in both retina and EPCs, leading to a concomitant suppression of retinal inflammation and correction of EPC number and function.
Increased dietary intake of ω-3-polyunsaturated fatty acids reduces pathological retinal angiogenesis
It is shown that increasing ω-3-PUFA tissue levels by dietary or genetic means decreased the avascular area of the retina by increasing vessel regrowth after injury, thereby reducing the hypoxic stimulus for neovascularization.
Global Prevalence and Major Risk Factors of Diabetic Retinopathy
Longer diabetes duration and poorer glycemic and blood pressure control are strongly associated with DR, and these data highlight the substantial worldwide public health burden of DR and the importance of modifiable risk factors in its occurrence.
Effects of n-6 PUFAs compared with SFAs on liver fat, lipoproteins, and inflammation in abdominal obesity: a randomized controlled trial.
Compared with SFA intake, n-6 PUFAs reduce liver fat and modestly improve metabolic status, without weight loss.
Incidence and progression of diabetic retinopathy: a systematic review.
Effect of essential fatty acids on glucose-induced cytotoxicity to retinal vascular endothelial cells
These results suggest that EFAs such as ALA and LA may have beneficial action in the prevention of high glucose-induced cellular damage, while the saturated fatty acid, palmitic acid was ineffective.